Protara Therapeutic shares owned by Citadel Advisors
Quarter-by-quarter ownership of Protara Therapeutic (TARA) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Protara Therapeutic
Tip: Access up to 7 years of quarterly data
All positions including Protara Therapeutic held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protara Therapeutic by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $72k | 39k | 1.87 |
| 2023-09-30 | $39k | 23k | 1.67 |
| 2023-06-30 | $24k | 10k | 2.39 |
| 2023-03-31 | $145k | 47k | 3.10 |
| 2022-12-31 | $44k | 16k | 2.68 |
| 2022-06-30 | $711k | 243k | 2.93 |
| 2022-03-31 | $2.1M | 406k | 5.11 |
| 2021-12-31 | $2.9M | 428k | 6.75 |
| 2021-09-30 | $2.4M | 346k | 6.92 |
| 2021-06-30 | $3.4M | 353k | 9.73 |
| 2021-03-31 | $3.8M | 242k | 15.74 |